CompletedPhase 2NCT02603926
Treatment of Fragile-X Associated Tremor/Ataxia Syndrome (FXTAS) With Allopregnanolone
Studying Fragile X-associated tremor/ataxia syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Randi J. Hagerman, MD
- Principal Investigator
- Randi J Hagerman, MD, M.DUC Davis MIND Institute
- Intervention
- Allopregnanolone(drug)
- Enrollment
- 6 enrolled
- Eligibility
- 50-85 years · All sexes
- Timeline
- 2015 – 2017
Study locations (1)
- UC Davis MIND Institute, Sacramento, California, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02603926 on ClinicalTrials.gov